Complications Encountered with a Transfemorally Placed Port-Catheter System for Hepatic Artery Chemotherapy Infusion

2001 ◽  
Vol 24 (2) ◽  
pp. 90-93 ◽  
Author(s):  
Toshiro Kuroiwa ◽  
Hiroshi Honda ◽  
Kengo Yoshimitsu ◽  
Hiroyuki Irie ◽  
Hitoshi Aibe ◽  
...  
1999 ◽  
Vol 22 (4) ◽  
pp. 344-347 ◽  
Author(s):  
Noboru Shindoh ◽  
Yutaka Ozaki ◽  
Shinsuke Kyogoku ◽  
Daigo Yamana ◽  
Yukiharu Sumi ◽  
...  

1988 ◽  
Vol 10 (4) ◽  
pp. 434-436 ◽  
Author(s):  
Laura F. Hutchins ◽  
R. Timothy Webb ◽  
Terry J. Ortego ◽  
Nicholas P. Lang ◽  
Farhad Navab

The Lancet ◽  
2003 ◽  
Vol 361 (9370) ◽  
pp. 1743
Author(s):  
David Kerr ◽  
Colin McArdle ◽  
Jonathan Ledermann ◽  
Irving Taylor

2003 ◽  
Vol 36 (8) ◽  
pp. 1183-1188
Author(s):  
Hidekazu Yamamoto ◽  
Satoshi Nara ◽  
Yoshito Tanaka ◽  
Kouya Hida ◽  
Eiji Yamamoto ◽  
...  

1995 ◽  
Vol 13 (6) ◽  
pp. 1513-1519 ◽  
Author(s):  
E B Rubenstein ◽  
A Fender ◽  
K V Rolston ◽  
L S Elting ◽  
P Prasco ◽  
...  

PURPOSE To determine the ability of a physician assistant (PA) to insert, in an ambulatory setting, a peripheral subcutaneous implanted vascular-access device (VAD) and to evaluate the ability to transfer this training to a second PA. We also evaluated the performance and complications associated with this new device. PATIENTS AND METHODS The Peripheral Access System (PAS) Port catheter system (Sims-Deltec Inc, St Paul, MN) was inserted in patients who required long-term (> 3 months) vascular access for infusion therapy. RESULTS The first PA (PA-1) successfully inserted 57 of 62 devices (92%) after gaining experience with the technique in 10 patients (success rate, five of 10 [50%]; P = .003). The second PA (PA-2) was successful in eight of 10 initial attempts (80%) and 25 of 30 overall (83%). Complications were few and limited to phlebitis, thrombosis, and a low infection rate (0.2 per 1,000 catheter days). CONCLUSION PAs can be taught to insert a peripheral subcutaneous implanted VAD. This technique is transferable from one PA to another, and the device studied is appropriate for outpatient VAD programs.


The Lancet ◽  
2003 ◽  
Vol 361 (9370) ◽  
pp. 1742
Author(s):  
Adam Brooks ◽  
Philip Clingan ◽  
David Morris

2006 ◽  
Vol 47 (8) ◽  
pp. 775-779
Author(s):  
T. Yamagami ◽  
T. Kato ◽  
T. Hirota ◽  
R. Yoshimatsu ◽  
T. Matsumoto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document